Oncology News

Oncology

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Van Nostrand D et al. – With respect to the treatment of metastatic epithelial cell thyroid cancer, the %WBR48hr of 131–I helps identify those patients in whom the empiric therapeutic prescribed activity of 131–I may be increased or should be decreased so as not to exceed the MTA and that Sisson et al.'s thresholds published in 2003 are applicable.

 

Today in Endocrine Oncology...keeping you current

Targeting the RET Pathway in Thyroid Cancer
Clinical Cancer Research, 12/01/09

Neuroendocrine carcinomas arising in solid-organ transplant recipients: rare but aggressive malignancies
Oncology (Karger), 11/25/09

Malignant teratoma of the thyroid in a pregnant woman
Annals of Diagnostic Pathology, 11/23/09


Sponsor

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Sponsor

Send this Summary to a Colleague

Enter email address